Enhanced cellular therapy: revolutionizing adoptive cellular therapy

• Published in: Experimental hematology & oncology Vol. 13; no. 1; pp. 47 - 23
• Main Authors: Xu, Meng-Yao, Zeng, Na, Liu, Chen-Qian, Sun, Jian-Xuan, An, Ye, Zhang, Si-Han, Xu, Jin-Zhou, Zhong, Xing-Yu, Ma, Si-Yang, He, Hao-Dong, Hu, Jia, Xia, Qi-Dong, Wang, Shao-Gang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 25.04.2024; BMC
• Subjects: Adoptive cellular therapy; Antimitotic agents; Antineoplastic agents; Biological products; Enhanced cellular therapy; Genetic engineering; Genetically modified organisms; Immune checkpoint inhibitor; Immunity; Immunotherapy; Medical colleges; Oncolytic virus; PROTAC; Proteolysis; Tumors; Oncolytic virus; Immune checkpoint inhibitor; Enhanced cellular therapy; PROTAC; Immunotherapy; Adoptive cellular therapy

Enhanced cellular therapy has emerged as a novel concept following the basis of cellular therapy. This treatment modality applied drugs or biotechnology to directly enhance or genetically modify cells to enhance the efficacy of adoptive cellular therapy (ACT). Drugs or biotechnology that enhance the...